Dan Polen - Polen Capital Management
Holding/activity history for Protagonist Therapeutics, Inc. (PTGX)
← All PTGX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 24,337 | 0.02 | Add 19.60% | <0.01 | $77.00–105.99 · VW $90.88i | $2,565,120 | SEC |
| 2025 Q4 | 20,349 | 0.01 | Add 0.12% | $62.24–96.54 · VW $83.04i | $1,777,282 | SEC | |
| 2025 Q3 | 20,325 | <0.01 | Add 27.04% | <0.01 | $49.38–68.26 · VW $58.83i | $1,350,190 | SEC |
| 2025 Q2 | 15,999 | <0.01 | Buy | <0.01 | $39.60–57.70 · VW $47.82i | $884,265 | SEC |
Price snapshot:
Current price$129.89
Avg. buy price$65.50
+/- since buy98.31%
52-week low$50.49
52-week high$141.10